VANDA PHARMACEUTICALS INC. — Revenue by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/b11003ca-91f6-424a-adcd-cf1a576ab940/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $216.1M | 2025-01-01 – 2025-12-31 | evidence 0001628280-26-007460 |
| FY 2024 | $198.8M | 2024-01-01 – 2024-12-31 | evidence 0001628280-25-005761 |
| FY 2023 | $192.6M | 2023-01-01 – 2023-12-31 | evidence 0001628280-24-003785 |
| FY 2022 | $254.4M | 2022-01-01 – 2022-12-31 | evidence 0001628280-23-002857 |
| FY 2021 | $268.7M | 2021-01-01 – 2021-12-31 | evidence 0001628280-22-003629 |
| FY 2020 | $248.2M | 2020-01-01 – 2020-12-31 | evidence 0001347178-21-000005 |
| FY 2019 | $227.2M | 2019-01-01 – 2019-12-31 | evidence 0001347178-20-000003 |
| FY 2018 | $193.1M | 2018-01-01 – 2018-12-31 | evidence 0001347178-19-000003 |
| FY 2017 | $165.1M | 2017-01-01 – 2017-12-31 | evidence 0001347178-19-000003 |
| FY 2016 | $146.0M | 2016-01-01 – 2016-12-31 | evidence 0001347178-19-000003 |
| FY 2015 | $109.9M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-461076 |
| FY 2014 | $12.9M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-091300 |
| FY 2013 | $33.9M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-066051 |
| FY 2012 | $32.7M | 2012-01-01 – 2012-12-31 | evidence 0001193125-14-066051 |
| FY 2011 | $31.3M | 2011-01-01 – 2011-12-31 | evidence 0001193125-14-066051 |
| FY 2010 | $35.7M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-105284 |
| FY 2009 | $4.5M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-105284 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
VANDA PHARMACEUTICALS INC. — all facts · Net Income · Operating Income